Dr. Eisele presents: Discovery and characterization of pathogenic transthyretin (TTR) oligomers in TTR-related amyloidosis

Published: August 10th, 2017

Category: Seminars

Date: August 24, 2017
Speaker(s): Yvonne S. Eisele, Ph.D.
Location: CTRB, 2004 Mowry Rd, Rm 3161

Please note that this seminar is located on the 3rd floor and occurs on a Thursday, instead of our regular Monday seminars.

Learning Objectives:  At the conclusion of this presentation, participants should be able to:

  1. Identify the evidence for the presence of non-native transthyretin (TTR) species in plasma of patients with TTR related amyloidosis
  2. Explain how the formation and pathogenicity of non-native TTR species can be assessed in vitro
  3. Classify structural and functional implications of non-native TTR species.

Dr. Eisele has disclosed no relevant financial relationships. No one else in a position to control content has any financial relationship(s) to disclose.

CME Information:

Accreditation:

The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit:

The University of Florida College of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The VA designates 1.0 hour of Continuing Education credit provided for its employees.

Series #8115

 If you have any questions regarding this seminar, please contact Dr. Christy Carter at cartercs@ufl.edu